Skip to main content
. 2021 Feb 15;21:92. doi: 10.1186/s12872-021-01902-0

Table 3.

Clinical outcomes

Variables Vildagliptin group (n = 10) Control group (n = 10) p Value
Cardiac death, % 0 0
Myocardial infarction, % 0 0
Cerebral infarction, % 0 0
Target lesion revascularization, % 0 10 1.000
Target vessel revascularization, % 0 20 0.473